<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">actabiomedica</journal-id><journal-title-group><journal-title xml:lang="ru">Acta Biomedica Scientifica</journal-title><trans-title-group xml:lang="en"><trans-title>Acta Biomedica Scientifica</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2541-9420</issn><issn pub-type="epub">2587-9596</issn><publisher><publisher-name>Scientific Centre for Family Health and Human Reproduction Problems</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.29413/ABS.2021-6.4.8</article-id><article-id custom-type="elpub" pub-id-type="custom">actabiomedica-2976</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КАРДИОЛОГИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CARDIOLOGY</subject></subj-group></article-categories><title-group><article-title>Взаимосвязь ишемической болезни сердца и коморбидного стоматологического фона</article-title><trans-title-group xml:lang="en"><trans-title>Relationship of coronary heart disease and comorbide dental background</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1795-4591</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Хаптанова</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Khaptanova</surname><given-names>V. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p> кандидат медицинских наук, доцент кафедры поликлинической терапии и общей врачебной практики</p><p>664003, г. Иркутск, ул. Красного Восстания, 1, Россия </p></bio><bio xml:lang="en"><p> Cand. Sc. (Med.), Associate Professor at the Department of Polyclinic Therapy and General Medical Practice</p><p> Krasnogo Vosstaniya str. 1, 664003 Irkutsk, Russian Federation </p></bio><email xlink:type="simple">haptanowa@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3750-0370</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гольменко</surname><given-names>А. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Golmenko</surname><given-names>A. D.</given-names></name></name-alternatives><bio xml:lang="ru"><p> доктор медицинских наук, профессор кафедры психодиагностики и практической психологии</p><p>664003, г. Иркутск, ул. Карла Маркса, 1, Россия </p></bio><bio xml:lang="en"><p> Dr. Sc. (Med.), Professor at the Department of Psychodiagnostics and Practical Psychology</p><p> Karla Marksa str. 1, 664003 Irkutsk, Russian Federation </p></bio><email xlink:type="simple">a.golmenko@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0240-0329</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Хаптанов</surname><given-names>А. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Khaptanov</surname><given-names>A. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p> ординатор кафедры терапевтической стоматологии</p><p>664003, г. Иркутск, ул. Красного Восстания, 1, Россия </p></bio><bio xml:lang="en"><p> Resident at the Department of Therapeutic Dentistry </p><p> Krasnogo Vosstaniya str. 1, 664003 Irkutsk, Russian Federation </p></bio><email xlink:type="simple">haptanov@bk.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1720-6323</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гамаюнов</surname><given-names>Д. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Gamayunov</surname><given-names>D. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p> студент 6-го курса лечебного факультета</p><p>664003, г. Иркутск, ул. Красного Восстания, 1, Россия </p></bio><bio xml:lang="en"><p> Student </p><p> Krasnogo Vosstaniya str. 1, 664003 Irkutsk, Russian Federation </p></bio><email xlink:type="simple">danil.gamayunov00@inbox.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО «Иркутский государственный медицинский университет» Минздрава России</institution></aff><aff xml:lang="en"><institution>Irkutsk State Medical University</institution></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБОУ ВО «Иркутский государственный университет»</institution></aff><aff xml:lang="en"><institution>Irkutsk State University </institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2021</year></pub-date><pub-date pub-type="epub"><day>12</day><month>10</month><year>2021</year></pub-date><volume>6</volume><issue>4</issue><fpage>87</fpage><lpage>99</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Хаптанова В.А., Гольменко А.Д., Хаптанов А.Ю., Гамаюнов Д.Ю., 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Хаптанова В.А., Гольменко А.Д., Хаптанов А.Ю., Гамаюнов Д.Ю.</copyright-holder><copyright-holder xml:lang="en">Khaptanova V.A., Golmenko A.D., Khaptanov A.Y., Gamayunov D.Y.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.actabiomedica.ru/jour/article/view/2976">https://www.actabiomedica.ru/jour/article/view/2976</self-uri><abstract><p>Сердечно-сосудистые заболевания имеют серьёзные экономические и социальные последствия, которые затрагивают людей, системы здравоохранения и общества во всём мире. Ишемическая болезнь сердца является одной из основных глобальных причин смерти населения, и в ближайшие годы прогнозируется её рост. Этот факт продолжает вызывать серьёзную озабоченность здравоохранения, социальных и экономических служб. Сердечно-сосудистые заболевания остаются наиболее частой причиной смерти, и стандартизованные по возрасту показатели выше для мужчин, чем для женщин. Сердечно-сосудистая коморбидность значительно увеличивается с возрастом. Сочетание ишемической болезни сердца и коморбидной патологии отмечается при онкологической заболеваемости, бронхиальной астме, неалкогольной жировой болезни печени, сахарном диабете второго типа, хронической обструктивной болезни лёгких, пародонтозе и др. Необходимо существующее заболевание анализировать с перенесёнными болезнями, факторами риска и предикторами, имеющимися у больного. Наличие сопутствующих заболеваний довольно часто требует проведения дополнительных диагностических методов и изменения тактики лечения ишемической болезни сердца ввиду того, что некоторые из них являются противопоказанием к применению определённых групп лекарственных препаратов. Заболевания пародонта включают широкий спектр воспалительных состояний, которые влияют на опорные структуры зубов, что может привести к потере зубов и способствовать системному воспалению. Заболевания пародонта связаны с несколькими системными заболеваниями, одним из которых является ишемическая болезнь сердца. Крайне важно, чтобы врачи понимали связь между заболеваниями пародонта и сердечно-сосудистыми заболеваниями. Комплексное лечение пародонтита и восстановление здорового пародонта могут помочь уменьшить общее воспаление в организме и снизить риски ишемической болезни сердца.</p></abstract><trans-abstract xml:lang="en"><p>Cardiovascular disease has serious economic and social consequences that affect people, health systems and societies around the world. Ischemic heart disease is one of the main global causes of death of the population, and its growth is predicted in the coming years. This fact continues to be of serious concern to health, social and economic services. Cardiovascular disease remains the most common cause of death, and age-standardized rates are higher for men than for women. Cardiovascular comorbidity increases significantly with age.The combination of ischemic heart disease and comorbid pathology is noted in cancer incidence, bronchial asthma, non-alcoholic fatty liver disease, type 2 diabetes mellitus, chronic obstructive pulmonary disease, periodontal disease, etc. It is necessary to analyze the existing disease with past diseases, risk factors and predictors available in the patient. The presence of concomitant diseases quite often requires additional diagnostic methods and changes in the tactics of treating coronary heart disease due to the fact that some of them are a contraindication to the use of certain groups of drugs. Periodontal disease includes a wide range of inflammatory conditions that affect the supporting structures of the teeth, which can lead to tooth loss and contribute to systemic inflammation. Periodontal disease is associated with several systemic diseases, one of which is coronary artery disease. It is imperative that clinicians understand the link between periodontal disease and cardiovascular disease. Comprehensive treatment of periodontitis and restoration of a healthy periodontium can help reduce overall inflammation in the body and reduce the risks of coronary heart disease.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>сердечно-сосудистые заболевания</kwd><kwd>ишемическая болезнь сердца</kwd><kwd>коморбидные болезни</kwd><kwd>пародонтоз</kwd></kwd-group><kwd-group xml:lang="en"><kwd>cardiovascular diseases</kwd><kwd>ischemic heart disease</kwd><kwd>comorbide diseases</kwd><kwd>periodontal disease</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Timmis A, Townsend N, Gale CP, Torbica A, Lettino M, Petersen SE, et al. European Society of Cardiology: Cardiovascular Disease Statistics 2019. Eur Heart J. 2020; 41(1): 12-85. doi: 10.1093/eurheartj/ehz859</mixed-citation><mixed-citation xml:lang="en">Timmis A, Townsend N, Gale CP, Torbica A, Lettino M, Petersen SE, et al. European Society of Cardiology: Cardiovascular Disease Statistics 2019. Eur Heart J. 2020; 41(1): 12-85. doi: 10.1093/eurheartj/ehz859</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Benjamin EJ, Virani SS, Callaway CW, Chamberlain AM, Chang AR, Cheng S, et al. Heart disease and stroke statistics – 2018 update: A report from the American Heart Association. Circulation. 2018; 137(12): e67-e492. doi: 10.1161/CIR.0000000000000558</mixed-citation><mixed-citation xml:lang="en">Benjamin EJ, Virani SS, Callaway CW, Chamberlain AM, Chang AR, Cheng S, et al. Heart disease and stroke statistics – 2018 update: A report from the American Heart Association. Circulation. 2018; 137(12): e67-e492. doi: 10.1161/CIR.0000000000000558</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Nowbar AN, Gitto M, Howard JP, Francis DP, Al-Lamee R. Mortality from ischemic heart disease. Circ Cardiovasc Qual Outcomes. 2019; 12(6): e005375. doi: 10.1161/CIRCOUTCOMES.118.005375</mixed-citation><mixed-citation xml:lang="en">Nowbar AN, Gitto M, Howard JP, Francis DP, Al-Lamee R. Mortality from ischemic heart disease. Circ Cardiovasc Qual Outcomes. 2019; 12(6): e005375. doi: 10.1161/CIRCOUTCOMES.118.005375</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Ященко С.Г., Козуля С.В., Рыбалко С.Ю., Бутырская И.Б. Болезни системы кровообращения в Республике Крым: заболеваемость, смертность, экономические потери. Таврический медико-биологический вестник. 2019; 22(3): 78-85.</mixed-citation><mixed-citation xml:lang="en">Yashchenko SG, Kozulya SV, Rybalko SYu, Butyrskaya IB. Diseases of the circulatory system in the Republic of Crimea: Morbidity, mortality, economic losses. Tavricheskiy mediko-biologicheskiy vestnik. 2019; 22(3): 78-85. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Shin J, Ham D, Shin S, Choi SK, Paik H-Y, Joung H. Effects of lifestyle-related factors on ischemic heart disease according to body mass index and fasting blood glucose levels in Korean adults. PLoS ONE. 2019; 14(5): e0216534. doi: 10.1371/journal.pone.0216534</mixed-citation><mixed-citation xml:lang="en">Shin J, Ham D, Shin S, Choi SK, Paik H-Y, Joung H. Effects of lifestyle-related factors on ischemic heart disease according to body mass index and fasting blood glucose levels in Korean adults. PLoS ONE. 2019; 14(5): e0216534. doi: 10.1371/journal.pone.0216534</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Boytsov SA, Demkina AE, Oshchepkova EV, Dolgusheva YA. Progress and problems of practical cardiology in Russia at the present stage. Kardiologiia. 2019; 59(3): 53-59. doi: 10.18087/cardio.2019.3.10242</mixed-citation><mixed-citation xml:lang="en">Boytsov SA, Demkina AE, Oshchepkova EV, Dolgusheva YA. Progress and problems of practical cardiology in Russia at the present stage. Kardiologiia. 2019; 59(3): 53-59. doi: 10.18087/cardio.2019.3.10242</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Huxley RR, Woodward M. Cigarette smoking as a risk factor for coronary heart disease in women compared with men: A systematic review and meta-analysis of prospective cohort studies. Lancet. 2011; 378(9799): 1297-1305. doi: 10.1016/S0140-6736(11)60781-2</mixed-citation><mixed-citation xml:lang="en">Huxley RR, Woodward M. Cigarette smoking as a risk factor for coronary heart disease in women compared with men: A systematic review and meta-analysis of prospective cohort studies. Lancet. 2011; 378(9799): 1297-1305. doi: 10.1016/S0140-6736(11)60781-2</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Campbell SC, Moffatt RJ, Stamford BA. Smoking and smoking cessation – the relationship between cardiovascular disease and lipoprotein metabolism: A review. Atherosclerosis. 2008; 201(2): 225-235. doi: 10.1016/j.atherosclerosis.2008.04.046</mixed-citation><mixed-citation xml:lang="en">Campbell SC, Moffatt RJ, Stamford BA. Smoking and smoking cessation – the relationship between cardiovascular disease and lipoprotein metabolism: A review. Atherosclerosis. 2008; 201(2): 225-235. doi: 10.1016/j.atherosclerosis.2008.04.046</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Cullen P, Schulte H, Assmann G. Smoking, lipoproteins and coronary heart disease risk: Data from the Münster Heart Study (PROCAM). Eur Heart J. 1998; 19(11): 1632-1641. doi: 10.1053/euhj.1998.1086</mixed-citation><mixed-citation xml:lang="en">Cullen P, Schulte H, Assmann G. Smoking, lipoproteins and coronary heart disease risk: Data from the Münster Heart Study (PROCAM). Eur Heart J. 1998; 19(11): 1632-1641. doi: 10.1053/euhj.1998.1086</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Brien SE, Ronksley PE, Turner BJ, Mukamal KJ, Ghali WA. Effect of alcohol consumption on biological markers associated with risk of coronary heart disease: Systematic review and meta-analysis of interventional studies. BMJ. 2011; 342: d636. doi: 10.1136/bmj.d636</mixed-citation><mixed-citation xml:lang="en">Brien SE, Ronksley PE, Turner BJ, Mukamal KJ, Ghali WA. Effect of alcohol consumption on biological markers associated with risk of coronary heart disease: Systematic review and meta-analysis of interventional studies. BMJ. 2011; 342: d636. doi: 10.1136/bmj.d636</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Ronksley PE, Brien SE, Turner BJ, Mukamal KJ, Ghali WA. Association of alcohol consumption with selected cardiovascular disease outcomes: A systematic review and meta-analysis. BMJ. 2011; 342: d671. doi: 10.1136/bmj.d671</mixed-citation><mixed-citation xml:lang="en">Ronksley PE, Brien SE, Turner BJ, Mukamal KJ, Ghali WA. Association of alcohol consumption with selected cardiovascular disease outcomes: A systematic review and meta-analysis. BMJ. 2011; 342: d671. doi: 10.1136/bmj.d671</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Gregg EW, Cheng YJ, Cadwell BL, Imperatore G, Williams DE, Flegal KM, et al. Secular trends in cardiovascular disease risk factors according to body mass index in US adults. JAMA. 2005; 293(15): 1868-1874. doi: 10.1001/jama.293.15.1868</mixed-citation><mixed-citation xml:lang="en">Gregg EW, Cheng YJ, Cadwell BL, Imperatore G, Williams DE, Flegal KM, et al. Secular trends in cardiovascular disease risk factors according to body mass index in US adults. JAMA. 2005; 293(15): 1868-1874. doi: 10.1001/jama.293.15.1868</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Mente A, de Koning L, Shannon HS, Anand SS. A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease. Arch Intern Med. 2009; 169(7): 659-669. doi: 10.1001/archinternmed.2009.38</mixed-citation><mixed-citation xml:lang="en">Mente A, de Koning L, Shannon HS, Anand SS. A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease. Arch Intern Med. 2009; 169(7): 659-669. doi: 10.1001/archinternmed.2009.38</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Yusuf S, Hawken S, Ôunpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. Lancet. 2004; 364(9438): 937-952. doi: 10.1016/S0140-6736(04)17018-9</mixed-citation><mixed-citation xml:lang="en">Yusuf S, Hawken S, Ôunpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. Lancet. 2004; 364(9438): 937-952. doi: 10.1016/S0140-6736(04)17018-9</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Stampfer MJ, Hu FB, Manson JE, Rimm EB, Willett WC. Primary prevention of coronary heart disease in women through diet and lifestyle. New Engl J Med. 2000; 343(1): 16-22. doi: 10.1056/NEJM200007063430103</mixed-citation><mixed-citation xml:lang="en">Stampfer MJ, Hu FB, Manson JE, Rimm EB, Willett WC. Primary prevention of coronary heart disease in women through diet and lifestyle. New Engl J Med. 2000; 343(1): 16-22. doi: 10.1056/NEJM200007063430103</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Sattelmair J, Pertman J, Ding EL, Kohl HW, Haskell W, Lee I-M. Dose response between physical activity and risk of coronary heart disease: A meta-analysis. Circulation. 2011; 124(7): 789-795. doi: 10.1161/CIRCULATIONAHA.110.010710</mixed-citation><mixed-citation xml:lang="en">Sattelmair J, Pertman J, Ding EL, Kohl HW, Haskell W, Lee I-M. Dose response between physical activity and risk of coronary heart disease: A meta-analysis. Circulation. 2011; 124(7): 789-795. doi: 10.1161/CIRCULATIONAHA.110.010710</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Ko DT, Wijeysundera HC, Udell JA, Vaccarino V, Austin PC, Guo H, et al. Traditional cardiovascular risk factors and the presence of obstructive coronary artery disease in men and women. Can J Cardiol. 2014; 30(7): 820-826. doi: 10.1016/j.cjca.2014.04.032</mixed-citation><mixed-citation xml:lang="en">Ko DT, Wijeysundera HC, Udell JA, Vaccarino V, Austin PC, Guo H, et al. Traditional cardiovascular risk factors and the presence of obstructive coronary artery disease in men and women. Can J Cardiol. 2014; 30(7): 820-826. doi: 10.1016/j.cjca.2014.04.032</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Noda H, Iso H, Saito I, Konishi M, Inoue M, Tsugane S. The impact of the metabolic syndrome and its components on the incidence of ischemic heart disease and stroke: The Japan public health center-based study. Hypertens Res. 2009; 32(4): 289-298. doi: 10.1038/hr.2009.14</mixed-citation><mixed-citation xml:lang="en">Noda H, Iso H, Saito I, Konishi M, Inoue M, Tsugane S. The impact of the metabolic syndrome and its components on the incidence of ischemic heart disease and stroke: The Japan public health center-based study. Hypertens Res. 2009; 32(4): 289-298. doi: 10.1038/hr.2009.14</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Flegal KM. Body-mass index and all-cause mortality. Lancet. 2017; 389(10086): 2284-2285. doi: 10.1016/S0140-6736(17)31437-X</mixed-citation><mixed-citation xml:lang="en">Flegal KM.Body-mass index and all-cause mortality. Lancet. 2017; 389(10086): 2284-2285. doi: 10.1016/S0140-6736(17)31437-X</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Росстат. Здравоохранение в России 2019: Статистический сборник. М.; 2019: 170.</mixed-citation><mixed-citation xml:lang="en">Federal Service of State Statistics. Healthcare in Russia 2019: Statistical collection. Moscow; 2019: 170. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Российское кардиологическое общество. Клинические рекомендации. Стабильная ишемическая болезнь сердца. 2020: 114.</mixed-citation><mixed-citation xml:lang="en">Russian Society of Cardiology. Clinical guidelines. Stable ischemic heart disease. 2020: 114. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Попов А.П., Сопрунов Н.И. Заболевание сердца: ишемическая болезнь сердца (ИБС). Вестник науки. 2019; 2(11): 49-53.</mixed-citation><mixed-citation xml:lang="en">Popov AP, Soprunov NI. Heart disease: Ischemic heart disease (IHD). Science Bulletin. 2019; 42(11): 49-53. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Желихажева М.В. Проблема коморбидности у пациентов с ишемической болезнью сердца и сопутствующей онкологической патологией. Грудная и сердечно-сосудистая хирургия. 2019; 61(6): 485-490. doi: 10.24022/0236-2791-2019-61-6-485-490</mixed-citation><mixed-citation xml:lang="en">Zhelikhazheva MV. The problem of comorbidity in patients with coronary heart disease and concomitant oncological pathology. Russian Journal of Thoracic and Cardiovascular Surgery. 2019; 61(6): 485-490. (In Russ.). doi: 10.24022/0236-2791-2019-61-6-485-490</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Вёрткин А.Л., Румянцев М.А., Скотников А.С. Коморбидность в клинической практике. Часть 1. Архивъ внутренней медицины. 2011; (1): 16-20. doi: 10.20514/2226-6704-2011-0-1-16-20</mixed-citation><mixed-citation xml:lang="en">Vertkin AL, Rumyantsev MA, Skotnikov AS. Comorbidity in clinical practice. Part 1. The Russian Archives of Internal Medicine. 2011; (1): 16-20. (In Russ.). doi: 10.20514/2226-6704-2011-0-1-16-20</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Мелихова С.П., Шевцова В.И., Зуйкова А.А., Котова Ю.А. Изучение коморбидной патологии при сахарном диабете 2 типа как осложнении метаболического синдрома. Архивъ внутренней медицины. 2018; 8(5): 366-371. doi: 10.20514/2226-6704-2018-0-5-366-371</mixed-citation><mixed-citation xml:lang="en">Melikhova SP, Shevtsova VI, Zuikova AA, Kotova YuA. Study of comorbid pathology in type 2 diabetes mellitus as a complication of metabolic syndrome. The Russian Archives of Internal Medicine. 2018; 8(5): 366-371. (In Russ.). doi: 10.20514/2226-6704-2018-0-5-366-371</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Григорьева Н.Ю., Илюшина Т.П., Колосова К.С., Королева Н.Б., Стрельцова А.А., Соловьева Д.В. Особенности клинического течения хронической ишемической болезни сердца у больных с бронхиальной астмой. Архивъ внутренней медицины. 2020; 10(2): 131-138. doi: 10.20514/2226-6704-2020-10-2-131-138</mixed-citation><mixed-citation xml:lang="en">Grigoryeva NY, Ilyushina TP, Kolosova KS, Koroleva NB, Streltsova AA, Soloveva DV. Clinical course of coronary heart disease concomitant with asthma. The Russian Archives of Internal Medicine. 2020; 10(2): 131-138. (In Russ.). doi: 10.20514/2226-6704-2020-10-2-131-138</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Оганов Р.Г., Симаненков В.И., Бакулин И.Г., Бакулина Н.В., Барбараш О.Л., Бойцов С.А., и др. Коморбидная патология в клинической практике. Алгоритмы диагностики и лечения. Кардиоваскулярная терапия и профилактика. 2019; 18(1): 5-66. doi: 10.15829/1728-8800-2019-1-5-66</mixed-citation><mixed-citation xml:lang="en">Oganov RG, Simanenkov VI, Bakulin IG, Bakulina NV, Barbarash OL, Boytsov SA, et al. Comorbid pathology in clinical practice. Diagnostic and treatment algorithms. Cardiovascular Therapy and Prevention. 2019; 18(1): 5-66. (In Russ.). doi: 10.15829/1728-8800-2019-1-5-66</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Гендлин Г.Е., Емелина Е.И., Никитин И.Г., Васюк Ю.А. Современный взгляд на кардиотоксичность химиотерапии онкологических заболеваний, включающей антрациклиновые антибиотики. Российский кардиологический журнал. 2017; (3): 145-154. doi: 10.15829/1560-4071-2017-3-145-154</mixed-citation><mixed-citation xml:lang="en">Gendlin GE, Emelina EI, Nikitin IG, Vasyuk YuA. Modern view of the cardiotoxicity of cancer chemotherapy, including anthracycline antibiotics. Russian Journal of Cardiology. 2017; (3): 145-154. (In Russ.). doi: 10.15829/1560-4071-2017-3-145-154</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Сергеева В.В., Полонская И.И. Медико-социальные аспекты влияния коморбидной патологии на реабилитацию больных ишемической болезнью сердца после шунтирования коронарных артерий. Медицинское образование сегодня. 2019; 1(5): 20-33.</mixed-citation><mixed-citation xml:lang="en">Sergeeva VV, Polonskaya II. Medical and social aspects of the influence of comorbid pathology on the rehabilitation of patients with coronary heart disease after coronary artery bypass grafting. Medical Education Today. 2019; 1(5): 20-33. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Куценко М.А. Парадигма коморбидности: синтропия ХОБЛ и ИБС. Человек и лекарство. 2015; 57(11): 26-30.</mixed-citation><mixed-citation xml:lang="en">Kutsenko MA. The paradigm of comorbidity: Syntropy of COPD and ischemic heart disease. Chelovek i lekarstvo. 2015; 57(11): 26-30. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Хасанова З.И., Макарова Н.В. Ишемическая болезнь сердца. Анализ заболеваемости взрослого населения острой формой ишемической болезни сердца, а также смертности от них в Российской Федерации за 2012–2017 гг. Авиценна. 2020; 67: 20-23.</mixed-citation><mixed-citation xml:lang="en">Khasanova ZI, Makarova NV. Coronary artery disease. Analysis of the incidence of acute coronary heart disease in the adult population, as well as mortality from them in the Russian Federation for 2012. Avicenna. 2020; 67: 20-23. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Einarson TR, Acs A, Ludwig C, Panton UH. Economic burden of cardiovascular disease in type 2 diabetes: A systematic review. Value Health. 2018; 21(7): 881-890. doi: 10.1016/j.jval.2017.12.019</mixed-citation><mixed-citation xml:lang="en">Einarson TR, Acs A, Ludwig C, Panton UH. Economic burden of cardiovascular disease in type 2 diabetes: A systematic review. Value Health. 2018; 21(7): 881-890. doi: 10.1016/j.jval.2017.12.019</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">D’agostino RB, Sullivan L, Parise H, Kannel WB. Overweight and obesity as determinants of cardiovascular risk: The Framingham experience. Arch Intern Med. 2002; 162(16): 1867-1872. doi: 10.1001/archinte.162.16.1867</mixed-citation><mixed-citation xml:lang="en">D’agostino RB, Sullivan L, Parise H, Kannel WB. Overweight and obesity as determinants of cardiovascular risk: The Framingham experience. Arch Intern Med. 2002; 162(16): 1867-1872. doi: 10.1001/archinte.162.16.1867</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Yang HK, Han K, Kwon H-S, Park Y-M, Cho J-H, Yoon K-H, et al. Obesity, metabolic health, and mortality in adults: A nationwide population-based study in Korea. Sci Rep. 2016; 6: 30329. doi: 10.1038/srep30329</mixed-citation><mixed-citation xml:lang="en">Yang HK, Han K, Kwon H-S, Park Y-M, Cho J-H, Yoon K-H, et al. Obesity, metabolic health, and mortality in adults: A nationwide population-based study in Korea. Sci Rep. 2016; 6: 30329. doi: 10.1038/srep30329</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Jensen MK, Chiuve SE, Rimm EB, Dethlefsen C, Tjønneland A, Joensen AM, et al. Obesity, behavioral lifestyle factors, and risk of acute coronary events. Circulation. 2008; 117(24): 3062-3069. doi: 10.1161/CIRCULATIONAHA.107.759951</mixed-citation><mixed-citation xml:lang="en">Jensen MK, Chiuve SE, Rimm EB, Dethlefsen C, Tjønneland A, Joensen AM, et al. Obesity, behavioral lifestyle factors, and risk of acute coronary events. Circulation. 2008; 117(24): 3062-3069. doi: 10.1161/CIRCULATIONAHA.107.759951</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Abou-Raya S, Naeem A, Abou-El KH, El BS. Coronary artery disease and periodontal disease: Is there a link? Angiology. 2002; 53(2): 141-148. doi: 10.1177/000331970205300203</mixed-citation><mixed-citation xml:lang="en">Abou-Raya S, Naeem A, Abou-El KH, El BS. Coronary artery disease and periodontal disease: Is there a link? Angiology. 2002; 53(2): 141-148. doi: 10.1177/000331970205300203</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Noda H, Iso H, Saito I, Konishi M, Inoue M, Tsugane S. The impact of the metabolic syndrome and its components on the incidence of ischemic heart disease and stroke: the Japan public health center-based study. Hypertens Res. 2009; 32(4): 289-298. doi: 10.1038/hr.2009.14</mixed-citation><mixed-citation xml:lang="en">Noda H, Iso H, Saito I, Konishi M, Inoue M, Tsugane S. The impact of the metabolic syndrome and its components on the incidence of ischemic heart disease and stroke: the Japan public health center-based study. Hypertens Res. 2009; 32(4): 289-298. doi: 10.1038/hr.2009.14</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Nguyen E, Coleman CI, Kohn CG, Weeda ER. Ranolazine in patients with type 2 diabetes and chronic angina: A cost-effectiveness analysis and assessment of health-related quality-of-life. Int J Cardiol. 2018; 273: 34-38. doi: 10.1016/j.ijcard.2018.09.060</mixed-citation><mixed-citation xml:lang="en">Nguyen E, Coleman CI, Kohn CG, Weeda ER. Ranolazine in patients with type 2 diabetes and chronic angina: A cost-effectiveness analysis and assessment of health-related quality-of-life. Int J Cardiol. 2018; 273: 34-38. doi: 10.1016/j.ijcard.2018.09.060</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Ambrosio G, Tamargo J, Grant PJ. Non-haemodynamic anti-anginal agents in the management of patients with stable coronary artery disease and diabetes: A review of the evidence. Diab Vasc Dis Res. 2016; 13(2): 98-112. doi: 10.1177/1479164115609028</mixed-citation><mixed-citation xml:lang="en">Ambrosio G, Tamargo J, Grant PJ. Non-haemodynamic anti-anginal agents in the management of patients with stable coronary artery disease and diabetes: A review of the evidence. Diab Vasc Dis Res. 2016; 13(2): 98-112. doi: 10.1177/1479164115609028</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Amano A, Inaba H. Cardiovascular diseases and periodontal diseases. Clin Calcium. 2012; 22(1): 43-48.</mixed-citation><mixed-citation xml:lang="en">Amano A, Inaba H. Cardiovascular diseases and periodontal diseases. Clin Calcium. 2012; 22(1): 43-48.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Abou-Raya S, Abou-Raya A, Naim A, Abuelkheir H. Rheumatoid arthritis, periodontal disease and coronary artery disease. Clin Rheumatol. 2008; 27(4): 421-427. doi: 10.1007/s10067-007-0714-y</mixed-citation><mixed-citation xml:lang="en">Abou-Raya S, Abou-Raya A, Naim A, Abuelkheir H. Rheumatoid arthritis, periodontal disease and coronary artery disease. Clin Rheumatol. 2008; 27(4): 421-427. doi: 10.1007/s10067-007-0714-y</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang J, Chen L, Delzell E, Muntner P, Hillegass WB, Safford MM, et al. The association between inflammatory markers, serum lipids and the risk of cardiovascular events in patients with rheumatoid arthritis. Ann Rheum Dis. 2014; 73(7): 1301-1308. doi: 10.1136/annrheumdis-2013-204715</mixed-citation><mixed-citation xml:lang="en">Zhang J, Chen L, Delzell E, Muntner P, Hillegass WB, Safford MM, et al. The association between inflammatory markers, serum lipids and the risk of cardiovascular events in patients with rheumatoid arthritis. Ann Rheum Dis. 2014; 73(7): 1301-1308. doi: 10.1136/annrheumdis-2013-204715</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Liu P, Zhang Y, Wang SJ, Zhang FH, Zheng PH. Correlation between periodontal disease and coronary atherosclerotic heart disease. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2006; 28(2): 169-172.</mixed-citation><mixed-citation xml:lang="en">Liu P, Zhang Y, Wang SJ, Zhang FH, Zheng PH. Correlation between periodontal disease and coronary atherosclerotic heart disease. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2006; 28(2): 169-172.</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Lavelle C. Is periodontal disease a risk factor for coronary artery disease (CAD)? J Can Dent Assoc. 2002; 68(3): 176-180.</mixed-citation><mixed-citation xml:lang="en">Lavelle C. Is periodontal disease a risk factor for coronary artery disease (CAD)? J Can Dent Assoc. 2002; 68(3): 176-180.</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Parameter on systemic conditions affected by periodontal diseases. J Periodontol. 2000; 71(5): 880-883. doi: 10.1902/jop.2000.71.5-S.880</mixed-citation><mixed-citation xml:lang="en">Parameter on systemic conditions affected by periodontal diseases. J Periodontol. 2000; 71(5): 880-883. doi: 10.1902/jop.2000.71.5-S.880</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Kinane DF, Stathopoulou PG, Papapanou PN. Periodontal diseases. Nat Rev Dis Primers. 2017; 3: 17038. doi: 10.1038/nrdp.2017.38</mixed-citation><mixed-citation xml:lang="en">Kinane DF, Stathopoulou PG, Papapanou PN. Periodontal diseases. Nat Rev Dis Primers. 2017; 3: 17038. doi: 10.1038/nrdp.2017.38</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Ramenzoni LL, Lehner MP, Kaufmann ME, Wiedemeier D, Attin T, Schmidlin PR. Oral diagnostic methods for the detection of periodontal disease. Diagnostics (Basel). 2021; 11(3): 571. doi: 10.3390/diagnostics11030571</mixed-citation><mixed-citation xml:lang="en">Ramenzoni LL, Lehner MP, Kaufmann ME, Wiedemeier D, Attin T, Schmidlin PR. Oral diagnostic methods for the detection of periodontal disease. Diagnostics (Basel). 2021; 11(3): 571. doi: 10.3390/diagnostics11030571</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Amano A. Periodontal diseases and systemic diseases. Clin Calcium. 2017; 27(10): 1383-1391.</mixed-citation><mixed-citation xml:lang="en">Amano A. Periodontal diseases and systemic diseases. Clin Calcium. 2017; 27(10): 1383-1391.</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Brown LJ, Brunelle JA, Kingman A. Periodontal status in the United States, 1988–91: Prevalence, extent, and demographic variation. J Dent Res. 1996; 75: 672-683. doi: 10.1177/002203459607502S07</mixed-citation><mixed-citation xml:lang="en">Brown LJ, Brunelle JA, Kingman A. Periodontal status in the United States, 1988–91: Prevalence, extent, and demographic variation. J Dent Res. 1996; 75: 672-683. doi: 10.1177/002203459607502S07</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Nazir M, Al-Ansari A, Al-Khalifa K, Alhareky M, Gaffar B, Almas K. Global prevalence of periodontal disease and lack of its surveillance. Sci World J. 2020; 2020: 2146160. doi: 10.1155/2020/2146160</mixed-citation><mixed-citation xml:lang="en">Nazir M, Al-Ansari A, Al-Khalifa K, Alhareky M, Gaffar B, Almas K. Global prevalence of periodontal disease and lack of its surveillance. Sci World J. 2020; 2020: 2146160. doi: 10.1155/2020/2146160</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Eke PI, Wei L, Borgnakke WS, Thornton-Evans G, Zhang XY, Hua L, et al. Periodontitis prevalence in adults ≥ 65 years of age, in the USA. Periodontol 2000. 2016; 72(1): 76-95: doi: 10.1111/prd.12145</mixed-citation><mixed-citation xml:lang="en">Eke PI, Wei L, Borgnakke WS, Thornton-Evans G, Zhang XY, Hua L, et al. Periodontitis prevalence in adults ≥ 65 years of age, in the USA. Periodontol 2000. 2016; 72(1): 76-95: doi: 10.1111/prd.12145</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Douglass CW, Jette AM, Fox CH, Tennstedt SL, Joshi A, Feldman HA, et al. Oral health status of the elderly in New England. J Gerontol. 1993; 48(2): M39-46: doi: 10.1093/geronj/48.2.m39</mixed-citation><mixed-citation xml:lang="en">Douglass CW, Jette AM, Fox CH, Tennstedt SL, Joshi A, Feldman HA, et al. Oral health status of the elderly in New England. J Gerontol. 1993; 48(2): M39-46: doi: 10.1093/geronj/48.2.m39</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Eke PI, Borgnakke WS, Genco RJ. Recent epidemiologic trends in periodontitis in the USA. Periodontol 2000. 2020; 82(1): 257-267: doi: 10.1111/prd.12323</mixed-citation><mixed-citation xml:lang="en">Eke PI, Borgnakke WS, Genco RJ. Recent epidemiologic trends in periodontitis in the USA. Periodontol 2000. 2020; 82(1): 257-267: doi: 10.1111/prd.12323</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Rutger PG, Thomas I. Periodontitis and cardiovascular disease. Ther Umsch. 2008; 65(2): 121-126. doi: 10.1024/0040-5930.65.2.121</mixed-citation><mixed-citation xml:lang="en">Rutger PG, Thomas I. Periodontitis and cardiovascular disease. Ther Umsch. 2008; 65(2): 121-126. doi: 10.1024/0040-5930.65.2.121</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Persson GR, Persson RE. Cardiovascular disease and periodontitis: An update on the associations and risk. J Clin Periodontol. 2008; 35(8): 362-379: doi: 10.1111/j.1600-051X.2008.01281.x</mixed-citation><mixed-citation xml:lang="en">Persson GR, Persson RE. Cardiovascular disease and periodontitis: An update on the associations and risk. J Clin Periodontol. 2008; 35(8): 362-379: doi: 10.1111/j.1600-051X.2008.01281.x</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Foz MA, Romito AG, Bispo MC, Petrillo LC, Patel K, Suvan J, et al. Periodontal therapy and biomarkers related to cardiovascular risk. Minerva Stomatol. 2010; 59(5): 271-283.</mixed-citation><mixed-citation xml:lang="en">Foz MA, Romito AG, Bispo MC, Petrillo LC, Patel K, Suvan J, et al. Periodontal therapy and biomarkers related to cardiovascular risk. Minerva Stomatol. 2010; 59(5): 271-283.</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Nakajima T, Honda T, Domon H, Okui T, Kajita K, Ito H, et al. Periodontitis-associated up-regulation of systemic inflammatory mediator level may increase the risk of coronary heart disease. J Periodontal Res. 2010; 45(1): 116-122: doi: 10.1111/j.1600-0765.2009.01209.x</mixed-citation><mixed-citation xml:lang="en">Nakajima T, Honda T, Domon H, Okui T, Kajita K, Ito H, et al. Periodontitis-associated up-regulation of systemic inflammatory mediator level may increase the risk of coronary heart disease. J Periodontal Res. 2010; 45(1): 116-122: doi: 10.1111/j.1600-0765.2009.01209.x</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Arbes Jr SJ, Slade GD, Beck JD. Association between extent of periodontal attachment loss and self-reported history of heart attack: An analysis of NHANES III data. J Dent Res. 1999; 78(12): 1777-1782. doi: 10.1177/00220345990780120301</mixed-citation><mixed-citation xml:lang="en">Arbes Jr SJ, Slade GD, Beck JD. Association between extent of periodontal attachment loss and self-reported history of heart attack: An analysis of NHANES III data. J Dent Res. 1999; 78(12): 1777-1782. doi: 10.1177/00220345990780120301</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Buhlin K, Gustafsson A, Hаkansson J, Klinge B. Oral health and cardiovascular disease in Sweden. J Clin Periodontol. 2002; 29(3): 254-259. doi: 10.1034/j.1600-051x.2002.290312.x</mixed-citation><mixed-citation xml:lang="en">Buhlin K, Gustafsson A, Hаkansson J, Klinge B. Oral health and cardiovascular disease in Sweden. J Clin Periodontol. 2002; 29(3): 254-259. doi: 10.1034/j.1600-051x.2002.290312.x</mixed-citation></citation-alternatives></ref><ref id="cit60"><label>60</label><citation-alternatives><mixed-citation xml:lang="ru">Mattila KJ, Valle MS, Nieminen MS, Valtonen VV, Hietaniemi KL. Dental infections and coronary atherosclerosis. Atherosclerosis. 1993; 103(2): 205-211. doi: 10.1016/0021-9150(93)90263-t</mixed-citation><mixed-citation xml:lang="en">Mattila KJ, Valle MS, Nieminen MS, Valtonen VV, Hietaniemi KL. Dental infections and coronary atherosclerosis. Atherosclerosis. 1993; 103(2): 205-211. doi: 10.1016/0021-9150(93)90263-t</mixed-citation></citation-alternatives></ref><ref id="cit61"><label>61</label><citation-alternatives><mixed-citation xml:lang="ru">Ajwani S, Mattila KJ, Tilvis RS, Ainamo A. Periodontal disease and mortality in an aged population. Spec Care Dentist. 2003; 23(4): 125-130. doi: 10.1111/j.1754-4505.2003.tb00297.x</mixed-citation><mixed-citation xml:lang="en">Ajwani S, Mattila KJ, Tilvis RS, Ainamo A. Periodontal disease and mortality in an aged population. Spec Care Dentist. 2003; 23(4): 125-130. doi: 10.1111/j.1754-4505.2003.tb00297.x</mixed-citation></citation-alternatives></ref><ref id="cit62"><label>62</label><citation-alternatives><mixed-citation xml:lang="ru">Loos BG. Systemic effects of periodontitis. Ann R Australas Coll Dent Surg. 2006; 18: 27-29.</mixed-citation><mixed-citation xml:lang="en">Loos BG. Systemic effects of periodontitis. Ann R Australas Coll Dent Surg. 2006; 18: 27-29.</mixed-citation></citation-alternatives></ref><ref id="cit63"><label>63</label><citation-alternatives><mixed-citation xml:lang="ru">Beck JD, Offenbacher S. The association between periodontal diseases and cardiovascular diseases: A state-of-thescience review. Ann Periodontol. 2001; 6(1): 9-15. doi: 10.1902/annals.2001.6.1.9</mixed-citation><mixed-citation xml:lang="en">Beck JD, Offenbacher S. The association between periodontal diseases and cardiovascular diseases: A state-of-thescience review. Ann Periodontol. 2001; 6(1): 9-15. doi: 10.1902/annals.2001.6.1.9</mixed-citation></citation-alternatives></ref><ref id="cit64"><label>64</label><citation-alternatives><mixed-citation xml:lang="ru">Loesche WJ, Schork A, Terpenning MS, Chen YM, Dominguez BL, Grossman N. Assessing the relationship between dental disease and coronary heart disease in elderly U.S. veterans. J Am Dent Assoc. 1998; 129(3): 301-311. doi: 10.14219/jada.archive.1998.0204</mixed-citation><mixed-citation xml:lang="en">Loesche WJ, Schork A, Terpenning MS, Chen YM, Dominguez BL, Grossman N. Assessing the relationship between dental disease and coronary heart disease in elderly U.S. veterans. J Am Dent Assoc. 1998; 129(3): 301-311. doi: 10.14219/jada.archive.1998.0204</mixed-citation></citation-alternatives></ref><ref id="cit65"><label>65</label><citation-alternatives><mixed-citation xml:lang="ru">Naderi S, Merchant AT. The association between periodontitis and cardiovascular disease: An update. Curr Atheroscler Rep. 2020; 22(10): 52. doi: 10.1007/s11883-020-00878-0</mixed-citation><mixed-citation xml:lang="en">Naderi S, Merchant AT. The association between periodontitis and cardiovascular disease: An update. Curr Atheroscler Rep. 2020; 22(10): 52. doi: 10.1007/s11883-020-00878-0</mixed-citation></citation-alternatives></ref><ref id="cit66"><label>66</label><citation-alternatives><mixed-citation xml:lang="ru">Aditi P, Amit KD, Dhrubajyoti B, Veena K, Zaghlol R, Basyal B, et al. Periodontal inflammation and the risk of cardiovascular disease. Curr Atheroscler Rep. 2020; 22(7): 28. doi: 10.1007/s11883-020-00848-6</mixed-citation><mixed-citation xml:lang="en">Aditi P, Amit KD, Dhrubajyoti B, Veena K, Zaghlol R, Basyal B, et al. Periodontal inflammation and the risk of cardiovascular disease. Curr Atheroscler Rep. 2020; 22(7): 28. doi: 10.1007/s11883-020-00848-6</mixed-citation></citation-alternatives></ref><ref id="cit67"><label>67</label><citation-alternatives><mixed-citation xml:lang="ru">Söder PO, Söder B, Nowak J, Jogestrand T. Early carotid atherosclerosis in subjects with periodontal diseases. Stroke. 2005; 36(6): 1195-1200. doi: 10.1161/01.STR.0000165916.90593.cb</mixed-citation><mixed-citation xml:lang="en">Söder PO, Söder B, Nowak J, Jogestrand T. Early carotid atherosclerosis in subjects with periodontal diseases. Stroke. 2005; 36(6): 1195-1200. doi: 10.1161/01.STR.0000165916.90593.cb</mixed-citation></citation-alternatives></ref><ref id="cit68"><label>68</label><citation-alternatives><mixed-citation xml:lang="ru">Srivastava MC, Srivastava R, Verma PK, Gautam A. Metabolic syndrome and periodontal disease: An overview for physicians. J Family Med Prim Care. 2019; 8(11): 3492-3495. doi: 10.4103/jfmpc.jfmpc_866_19</mixed-citation><mixed-citation xml:lang="en">Srivastava MC, Srivastava R, Verma PK, Gautam A. Metabolic syndrome and periodontal disease: An overview for physicians. J Family Med Prim Care. 2019; 8(11): 3492-3495. doi: 10.4103/jfmpc.jfmpc_866_19</mixed-citation></citation-alternatives></ref><ref id="cit69"><label>69</label><citation-alternatives><mixed-citation xml:lang="ru">Lamster IB, Pagan M. Periodontal disease and the metabolic syndrome. Int Dent J. 2017; 67(2): 67-77. doi: 10.1111/idj.12264</mixed-citation><mixed-citation xml:lang="en">Lamster IB, Pagan M. Periodontal disease and the metabolic syndrome. Int Dent J. 2017; 67(2): 67-77. doi: 10.1111/idj.12264</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
